Varex Imaging Corporation

AI Score

0

Unlock

13.54
0.16 (1.20%)
At close: Jan 14, 2025, 3:59 PM
13.52
-0.15%
After-hours Jan 14, 2025, 04:00 PM EST

Company Description

Varex Imaging Corporation designs and manufactures X-ray imaging components.

The company operates in two segments, Medical and Industrial.

The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys.

This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses.

The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications.

Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users.

The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia.

Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.

Varex Imaging Corporation
Varex Imaging Corporation logo
Country United States
IPO Date Jan 23, 2017
Industry Medical - Devices
Sector Healthcare
Employees 2,300
CEO Sunny S. Sanyal

Contact Details

Address:
1678 South Pioneer Road
Salt Lake City, Utah
United States
Website https://www.vareximaging.com

Stock Details

Ticker Symbol VREX
Exchange NASDAQ
Fiscal Year November - October
Reporting Currency USD
CIK Code 0001681622
CUSIP Number 92214X106
ISIN Number US92214X1063
Employer ID 81-3434516
SIC Code 3679

Key Executives

Name Position
Sunny S. Sanyal President, Chief Executive Officer & Director
Kimberley E. Honeysett J.D. Chief Legal Officer, General Counsel & Corporate Secretary
Shubham Maheshwari Chief Financial Officer & Principal Accounting Officer
Andrew J. Hartmann Senior Vice President & GM of X-ray Detectors
Christopher John Belfiore Director of Investor Relations
David Carmona Vice President of Medical Global Sales & Marketing
Karen Aranki Chief Human Resources Officer
Mark S. Jonaitis Senior Vice President & GM of X-Ray Sources
Shaohua Liang Vice President & MD for China

Latest SEC Filings

Date Type Title
Jan 06, 2025 8-K/A [Amend] Current Report
Jan 02, 2025 DEFA14A Filing
Dec 30, 2024 ARS Filing
Dec 30, 2024 DEFA14A Filing
Dec 30, 2024 DEF 14A Filing
Dec 23, 2024 8-K Current Report
Dec 18, 2024 4 Filing
Dec 18, 2024 4 Filing
Dec 18, 2024 4 Filing
Dec 18, 2024 4 Filing